 | • レポートコード：QYR9ST05463 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、デュルバルマブの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、2.4mL注射、10mL注射に、用途別には、局所進行性尿路上皮癌、転移性尿路上皮癌、その他にセグメント区分し、デュルバルマブの世界市場を分析しました。 ・エグゼクティブ・サマリー ・デュルバルマブの世界市場概要 ・デュルバルマブの製造コスト構成分析 ・デュルバルマブの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・デュルバルマブの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・デュルバルマブのセグメント分析（種類別） （2.4mL注射、10mL注射） ・デュルバルマブのセグメント分析（用途別） （局所進行性尿路上皮癌、転移性尿路上皮癌、その他） ・デュルバルマブの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Medimmune (AstraZeneca)） ・デュルバルマブの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Durvalumab market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Durvalumab volume and value at global level, regional level and company level. From a global perspective, this report represents overall Durvalumab market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Durvalumab in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Durvalumab manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Medimmune (AstraZeneca)
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
2.4mL Injection
10mL Injection
Segment by Application
Locally Advanced Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Other
Table of Contents
Executive Summary
1 Industry Overview of Durvalumab
1.1 Definition of Durvalumab
1.2 Durvalumab Segment by Type
1.2.1 Global Durvalumab Production Growth Rate Comparison by Types (2014-2025)
1.2.2 2.4mL Injection
1.2.3 10mL Injection
1.3 Durvalumab Segment by Applications
1.3.1 Global Durvalumab Consumption Comparison by Applications (2014-2025)
1.3.2 Locally Advanced Urothelial Carcinoma
1.3.3 Metastatic Urothelial Carcinoma
1.3.4 Other
1.4 Global Durvalumab Overall Market
1.4.1 Global Durvalumab Revenue (2014-2025)
1.4.2 Global Durvalumab Production (2014-2025)
1.4.3 North America Durvalumab Status and Prospect (2014-2025)
1.4.4 Europe Durvalumab Status and Prospect (2014-2025)
1.4.5 China Durvalumab Status and Prospect (2014-2025)
1.4.6 Japan Durvalumab Status and Prospect (2014-2025)
1.4.7 Southeast Asia Durvalumab Status and Prospect (2014-2025)
1.4.8 India Durvalumab Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Durvalumab
2.3 Manufacturing Process Analysis of Durvalumab
2.4 Industry Chain Structure of Durvalumab
3 Development and Manufacturing Plants Analysis of Durvalumab
3.1 Capacity and Commercial Production Date
3.2 Global Durvalumab Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Durvalumab
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Durvalumab Production and Capacity Analysis
4.2 Durvalumab Revenue Analysis
4.3 Durvalumab Price Analysis
4.4 Market Concentration Degree
5 Durvalumab Regional Market Analysis
5.1 Durvalumab Production by Regions
5.1.1 Global Durvalumab Production by Regions
5.1.2 Global Durvalumab Revenue by Regions
5.2 Durvalumab Consumption by Regions
5.3 North America Durvalumab Market Analysis
5.3.1 North America Durvalumab Production
5.3.2 North America Durvalumab Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Durvalumab Import and Export
5.4 Europe Durvalumab Market Analysis
5.4.1 Europe Durvalumab Production
5.4.2 Europe Durvalumab Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Durvalumab Import and Export
5.5 China Durvalumab Market Analysis
5.5.1 China Durvalumab Production
5.5.2 China Durvalumab Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Durvalumab Import and Export
5.6 Japan Durvalumab Market Analysis
5.6.1 Japan Durvalumab Production
5.6.2 Japan Durvalumab Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Durvalumab Import and Export
5.7 Southeast Asia Durvalumab Market Analysis
5.7.1 Southeast Asia Durvalumab Production
5.7.2 Southeast Asia Durvalumab Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Durvalumab Import and Export
5.8 India Durvalumab Market Analysis
5.8.1 India Durvalumab Production
5.8.2 India Durvalumab Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Durvalumab Import and Export
6 Durvalumab Segment Market Analysis (by Type)
6.1 Global Durvalumab Production by Type
6.2 Global Durvalumab Revenue by Type
6.3 Durvalumab Price by Type
7 Durvalumab Segment Market Analysis (by Application)
7.1 Global Durvalumab Consumption by Application
7.2 Global Durvalumab Consumption Market Share by Application (2014-2019)
8 Durvalumab Major Manufacturers Analysis
8.1 Medimmune (AstraZeneca)
8.1.1 Medimmune (AstraZeneca) Durvalumab Production Sites and Area Served
8.1.2 Medimmune (AstraZeneca) Product Introduction, Application and Specification
8.1.3 Medimmune (AstraZeneca) Durvalumab Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
9 Development Trend of Analysis of Durvalumab Market
9.1 Global Durvalumab Market Trend Analysis
9.1.1 Global Durvalumab Market Size (Volume and Value) Forecast 2019-2025
9.2 Durvalumab Regional Market Trend
9.2.1 North America Durvalumab Forecast 2019-2025
9.2.2 Europe Durvalumab Forecast 2019-2025
9.2.3 China Durvalumab Forecast 2019-2025
9.2.4 Japan Durvalumab Forecast 2019-2025
9.2.5 Southeast Asia Durvalumab Forecast 2019-2025
9.2.6 India Durvalumab Forecast 2019-2025
9.3 Durvalumab Market Trend (Product Type)
9.4 Durvalumab Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Durvalumab Distributors List
10.3 Durvalumab Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Durvalumab
Table Global Durvalumab Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Durvalumab Production Market Share by Types in 2018
Figure 2.4mL Injection Product Picture
Figure 10mL Injection Product Picture
Table Global Durvalumab Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Durvalumab Consumption Market Share by Applications in 2018
Figure Locally Advanced Urothelial Carcinoma
Figure Metastatic Urothelial Carcinoma
Figure Other
Figure Global Durvalumab Revenue (Million USD) (2014-2025)
Figure Global Durvalumab Production (K Pcs) (2014-2025)
Figure North America Durvalumab Market Size (Million USD) (2014-2025)
Figure Europe Durvalumab Market Size (Million USD) (2014-2025)
Figure China Durvalumab Market Size (Million USD) (2014-2025)
Figure Japan Durvalumab Market Size (Million USD) (2014-2025)
Figure Southeast Asia Durvalumab Market Size (Million USD) (2014-2025)
Figure India Durvalumab Market Size (Million USD) (2014-2025)
Table Durvalumab Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Durvalumab in 2018
Figure Manufacturing Process Analysis of Durvalumab
Figure Industry Chain Structure of Durvalumab
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Durvalumab Manufacturing Plants Distribution
Table Durvalumab Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Durvalumab Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Durvalumab Production (K Pcs) of Major Manufacturers (2014-2019)
Table Durvalumab Production Market Share of Major Manufacturers (2014-2019)
Figure Durvalumab Production Share by Manufacturers in 2018
Table Durvalumab Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Durvalumab Revenue Market Share of Major Manufacturers (2014-2019)
Figure Durvalumab Revenue Share by Manufacturers in 2018
Table Durvalumab Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Durvalumab Production by Regions 2014-2019 (K Pcs)
Table Global Durvalumab Production Market Share by Regions 2014-2019
Figure Global Durvalumab Production Market Share by Regions in 2018
Table Global Durvalumab Revenue by Regions 2014-2019 (Million USD)
Table Global Durvalumab Revenue Market Share by Regions 2014-2019
Figure Global Durvalumab Revenue Market Share by Regions in 2018
Table Global Durvalumab Consumption by Regions 2014-2019 (K Pcs)
Table Global Durvalumab Consumption Market Share by Regions 2014-2019
Figure North America Durvalumab Production Growth Rate 2014-2019 (K Pcs)
Figure North America Durvalumab Revenue Growth Rate 2014-2019 (Million USD)
Table North America Durvalumab Production, Consumption Import and Export (K Pcs)
Figure Europe Durvalumab Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Durvalumab Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Durvalumab Production, Consumption Import and Export (K Pcs)
Figure China Durvalumab Production Growth Rate 2014-2019 (K Pcs)
Figure China Durvalumab Revenue Growth Rate 2014-2019 (Million USD)
Table China Durvalumab Production, Consumption Import and Export (K Pcs)
Figure Japan Durvalumab Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Durvalumab Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Durvalumab Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Durvalumab Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Durvalumab Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Durvalumab Production, Consumption Import and Export (K Pcs)
Figure India Durvalumab Production Growth Rate 2014-2019 (K Pcs)
Figure India Durvalumab Revenue Growth Rate 2014-2019 (Million USD)
Table India Durvalumab Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Durvalumab Market Share by Application (2014-2019)
Figure Global Value (Consumption) Durvalumab Market Share by Application (2014-2019)
Table Medimmune (AstraZeneca) Durvalumab Production Sites and Area Served
Table Medimmune (AstraZeneca) Durvalumab Product Introduction, Application and Specification
Table Medimmune (AstraZeneca) Durvalumab Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Medimmune (AstraZeneca) Durvalumab Production Growth Rate (2014-2019)
Table Medimmune (AstraZeneca) Durvalumab Production Market Share (2014-2019)
Figure Medimmune (AstraZeneca) Durvalumab Revenue Market Share (2014-2019)
Table Medimmune (AstraZeneca) Durvalumab Main Business and Markets Served
Figure Global Durvalumab Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Durvalumab Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Durvalumab Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Durvalumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Durvalumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Durvalumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Durvalumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Durvalumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Durvalumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Durvalumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Durvalumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Durvalumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Durvalumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Durvalumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Durvalumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Durvalumab by Type (2019-2025)
Table Global Consumption (K Pcs) of Durvalumab by Application (2019-2025)
Table Durvalumab Distributors List
Table Durvalumab Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のデュルバルマブ市場：専門的調査 The global Durvalumab market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Durvalumab volume and value at global level, regional level and company level. From a global perspective, this report …- 尿路上皮がん薬の世界市場：市場規模・現状・予測 Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounte…
- 尿路上皮がん薬の世界市場：市場規模・現状・予測 Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounte…
- 進行腎細胞癌治療薬の世界市場：市場規模・現状・予測 Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell …
- 副腎皮質癌治療の世界市場：市場規模・現状・予測 Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…